vs.MS is a global initiative focused on highlighting and addressing the sometimes debilitating symptoms that accompany MS, as well as their daily impact on people living with and affected by the disease.
The physical and emotional toll patients face on a day-to-day basis were revealed in a global survey conducted by Sanofi Genzyme of 1,500 people living with relapsing MS (RMS) and their care partners in seven countries.
